High Treatment Adherence, Satisfaction, Motivation, and Health-Related Quality of Life With Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis &Ndash; Results From a 24-Month, Multicenter, Open-Label Danish Study

Patient Preference and Adherence - New Zealand
doi 10.2147/ppa.s166278
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Multiple Sclerosis International
Neurology
2015English

Pnd116 - A Three Month Interim Analysis of Fingolimod Treatment Adherence for Relapsing Remitting Multiple Sclerosis in the Uk: The Patient Reported Outcomes With Fingolimod in Local Experience (Profile) Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Treatment of Remitting-Relapsing Multiple Sclerosis (MS) With Cladribine: Results of an Open Pilot Study at 18 Months

Journal of Neurology
Neurology
1996English

Treatment Satisfaction and Quality of Life in Patients Treated With Fingolimod

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2018English

Disease-Modifying Therapies in Relapsing–remitting Multiple Sclerosis

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2010English

Health State Utilities in Patients With Relapsing Remitting Multiple Sclerosis Treated With Cladribine Tablets

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
1999English

Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients With Relapsing Forms of Multiple Sclerosis (MANAGE)

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2016English

The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy